...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Analysis of amino acid and monoamine neurotransmitters and their metabolites in rat urine of Alzheimer's disease using in situ ultrasound-assisted derivatization dispersive liquid-liquid microextraction with UHPLC-MS/MS
【24h】

Analysis of amino acid and monoamine neurotransmitters and their metabolites in rat urine of Alzheimer's disease using in situ ultrasound-assisted derivatization dispersive liquid-liquid microextraction with UHPLC-MS/MS

机译:用UHPLC-MS / MS的原位超声辅助衍生分散液 - 液体微萃取氨基酸和单胺神经递质及其在阿尔茨海默病大鼠尿中的代谢物

获取原文
获取原文并翻译 | 示例
           

摘要

Neurotransmitters (NTs) may play an important role in neuro degenerative disorders such as Alzheimer's disease (AD). In order to investigate the potential links, a new simple, fast, accurate and sensitive analytical method, based on in situ ultrasound-assisted derivatization dispersive liquid-liquid microex-traction (in situ UA-DDLLME) coupled with ultra high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS), has been developed and validated. The quantitation of amino acid neu-rotransmitters (AANTs) and monoamine neurotransmitters (MANTs) in urine of AD rats were performed in this work. The in situ UA-DDLLME procedure involved the rapid injection of the mixture of low toxic 4-bromoanisole (extractant) and acetonitrile (dispersant), which containing the new designed and synthesized 4'-carbonyl chloride rosamine (CCR) as derivatization reagent, into the aqueous phase of real sample and buffer. Under the selected conditions, the derivatization and microextraction of analytes were simultaneously completed within 1 min. Good linearity for each analyte (R > 0.992) was observed with low limit of detections (LODs, S/N > 3). Moreover, the proposed method was compared with direct detection or other reported methods, and the results showed that low matrix effects and good recoveries results were obtained in this work. Taken together, in situ UA-DDLLME coupled with UHPLC-MS/MS analysis was demonstrated to be a good method for sensitive, accurate and simultaneous monitoring of AANTs and MANTs. This method would be expected to be highly useful in AD diseases' clinical diagnostics and may have potential value in monitoring the efficacy of treatment. (C) 2016 Elsevier B.V. All rights reserved.
机译:神经递质(NTS)可能在神经退行性疾病(如阿尔茨海默病(AD)中发挥重要作用。为了研究潜在的链接,一种新的简单,快速,准确和敏感的分析方法,基于原位超声辅助衍生化分散液 - 液体微脂牵引(原位UA-DDLLME)与超高效液相色谱相结合已经开发和验证了串联质谱(UHPLC-MS / MS)。在这项工作中进行尿氨基酸Neu-Rotoransmitters(Antane)和单胺神经递质的定量。原位UA-DDLLME程序涉及快速注射低毒4-溴烷(萃取剂)和乙腈(分散剂)的混合物,其含有新设计和合成的4'-羰基氯酰胺(CCR)作为衍生化试剂,进入真实样品和缓冲液的水相。在所选条件下,分析物的衍生化和微萃取在1分钟内同时完成。观察到每个分析物(R> 0.992)的良好线性,具有低的检测限(LOD,S / N> 3)。此外,将所提出的方法与直接检测或其他报道的方法进行比较,结果表明,在这项工作中获得了低基质效应和良好的回收率。总之,与UHPLC-MS / MS / MS分析相结合的原位UA-DDLLME被证明是敏感,准确和同时监测Aant和Mants的良好方法。预计该方法将在AD疾病的临床诊断中非常有用,并且可能具有监测治疗疗效的潜在价值。 (c)2016 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号